Avacta Group Plc (AIM:AVCT)
London · Delayed Price · Currency is GBP · Price in GBX 74.00
+2.00 (2.78%)
At close: Apr 15, 2026
Avacta Group Market Cap
Avacta Group has a market cap or net worth of 335.43 million as of April 15, 2026. Its market cap has increased by 168.58% in one year.
Market Cap
335.43M
Enterprise Value
343.18M
Revenue
113.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
74.00
Market Cap Chart
Since September 29, 2006, Avacta Group's market cap has increased from 37.46M to 335.43M, an increase of 795.43%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 335.43M | 33.43% |
| Dec 31, 2025 | 251.39M | 37.41% |
| Dec 31, 2024 | 182.95M | -43.88% |
| Dec 29, 2023 | 325.99M | 9.26% |
| Dec 30, 2022 | 298.35M | -5.82% |
| Dec 31, 2021 | 316.78M | 11.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 1.80B |
| Oxford Nanopore Technologies | 1.09B |
| Oxford Biomedica | 755.63M |
| PureTech Health | 319.85M |
| Scancell Holdings | 129.72M |
| Bioventix | 95.35M |
| 4basebio | 78.16M |
| hVIVO | 59.19M |